Study Design: A prospective follow-up study to detect the early neurological improvement after decompression surgery and to clarify its correlation with the late neurological outcome in patients with cervical compression myelopathy.
Objective: To reveal the suitability of a simple performance, 15-second grip-and-release test for postoperative neurological recovery in patients with cervical myelopathy.
Summary Of Background Data: Although various parameters have been advocated as prognostic factors, there still remain arguments against them. Furthermore, neurological status after decompression surgery has been evaluated weekly or monthly in previous studies, but not hourly or daily. To follow the postoperative neurological recovery, we used our original performance test.
Methods: Forty-eight patients who were admitted to undergo decompressive laminoplasty for cervical myelopathy were enrolled in the study. Twenty-five patients who were admitted for lumbar spine surgery were used as controls. Subjects were asked to fully grip and release with their right (or left) hand fingers as fast as possible for 15 seconds, which was recorded by a digital camera. And the number of grip-and-release cycles was counted (15-second test) in the recorded video files.
Results: In the myelopathy group, the number of grip-and-release cycles before surgery and 4 hours, 24 hours, 48 hours, 1 week, and 2 weeks after surgery was 26.7 ± 10.0, 29.7 ± 9.9, 35.0 ± 11.3, 35.1 ± 9.8, 36.2 ± 9.6, and 37.2 ± 10.2, respectively. The number increased steeply after surgery until 24 hours, and the number was 94% after 24 hours of the number recorded 2 weeks after surgery. In the control group, the number of grip-and-release cycles at each time point was 37.9 ± 9.7, 34.7 ± 9.1, 39.2 ± 9.0, 38.5 ± 8.9, 38.9 ± 9.7, and 38.0 ± 9.3, respectively. There was a transient reduction 4 hours after surgery.
Conclusion: Because the number recorded 24 hours after surgery was significantly correlated with both the maximum gain in the number on the 15-second test and the gain in the Japan Orthopaedic Association score, it could be used as a prognostic factor for neurological outcome in patients with cervical myelopathy.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/BRS.0b013e31824ac3d4 | DOI Listing |
Jpn J Clin Oncol
January 2025
Department of Otorhinolaryngology, Head and Neck Surgery, Yokohama City University, School of Medicine, Yokohama, Japan.
The prognosis for T2N0 glottic squamous cell carcinoma (SCC) is generally favorable, with a 5-year overall survival rate of 79%-96% achieved with radiotherapy (RT), the standard nonsurgical treatment for this condition. However, the local control rate for T2N0 glottic SCC treated with RT remains suboptimal, with a 5-year local control rate of only 65%-80%. Local residual disease or recurrence following RT for T2N0 glottic SCC often leads to difficulties in laryngeal preservation.
View Article and Find Full Text PDFEndocrine
January 2025
Centro di Ricerca e Innovazione sulle Patologie Surrenaliche, AOU Careggi, Florence, Italy.
Purpose: To compare functional deficits associated to surgery with those caused by the growth of the head and neck paragangliomas (HNPGLs).
Methods: 72 patients with HNPGLs were included. Patients were divided in group A (49 patients undergoing surgery) and group B (23 patients following a wait and see approach).
BMC Cancer
January 2025
Department of Radiation Oncology, First Affiliated Hospital of Kunming Medical University, 295 Xichang Road, Kunming, 650032, P. R. China.
Introduction: The core objective of this study was to precisely locate metastatic lymph nodes, identify potential areas in nasopharyngeal carcinoma patients that may not require radiotherapy, and propose a hypothesis for reduced target volume radiotherapy on the basis of these findings. Ultimately, we reassessed the differences in dosimetry of organs at risk (OARs) between reduced target volume (reduced CTV2) radiotherapy and standard radiotherapy.
Methods And Materials: A total of 209 patients participated in the study.
J Ovarian Res
January 2025
Department of Gynecology, Obstetrics and Gynecology Hospital of Fudan University, #128 Shenyang Road, Shanghai, 200090, People's Republic of China.
Background: Ovarian cancers (OC) and cervical cancers (CC) have poor survival rates. Tumor-infiltrating lymphocytes (TILs) play a pivotal role in prognosis, but shared immune mechanisms remain elusive.
Methods: We integrated single-cell RNA sequencing (scRNA-seq) and spatial transcriptomics (ST) to explore immune regulation in OC and CC, focusing on the PI3K/AKT pathway and FLT3 as key modulators.
Eur Arch Otorhinolaryngol
January 2025
Department of Otorhinolaryngology-Head and Neck Surgery, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan.
Objective: Intraoperative systems for monitoring facial nerve function, in which temporal electrical stimulation is applied to the facial nerve through electrodes, are used in many surgeries requiring facial nerve preservation; however, continuous stimulation or quantitative evaluation of facial nerve function is difficult with this approach. We examined the usefulness of a continuous and quantitative facial nerve-monitoring system for temporal bone lesions by using our experience to modify the existing methods used for cases involving vestibular schwannomas.
Study Design: Retrospective observational study.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!